ASPREE Trial:

ASPREE GP Newsletter October

The ASPREE study is currently recruiting in the Geelong region. This study, for the first time, will determine whether the potential benefits of aspirin outweigh the risks for people over age 70.

The Trial -

ASPREE is a randomised, double-blind placebo controlled study It involves both males and females, 70 years and older Participants are randomly assigned (or randomised) to take either a low-dose aspirin tablet (100mg) or a placebo tablet (dummy pill) for a period of 5 years The study will recruit 19,000 healthy participants through regional centres (both in urban and rural locations throughout Australia and the United States) Annual follow-ups will involve a number of health, clinical and other measurements Any abnormalities will be reported to the participant's doctor for further assessment

People are eligible to take part in this study if they are:

aged 70 years or over willing and able to provide informed consent

People cannot take part if they:

have blood vessel disease. have a serious illness. are allergic to aspirin or cannot take it. have had or are at risk of serious bleeding. are taking other 'blood thinning' medication. have seriously impaired mental or physical function.

For more information please contact:

1800 728 745 or visit website www.aspree.org

 Zoster Vaccine Research Trial- Communicate from Dr. Eugene Athan

Participants are required for the following projects:

PREGNANT WOMEN REQUIRED FOR A STUDY ON MATERNAL AND INFANT WELLBEING: PRE- AND POST BIRTH

The purpose of this project is to investigate women's general experiences during pregnancy and the first 12 months following birth. This includes issues associated with general mood as well as experiences related to self-esteem, body image, relationship quality and parental stress.   

The project aims to provide some insight into questions regarding the level and type of distress experienced by women across pregnancy and the first postpartum year, and whether any 'critical periods' can be identified where early intervention may be most effective. The identification of risk factors and consequences to maternal distress during pregnancy and the postpartum will also be explored.

In order to obtain accurate and meaningful results, we aim to recruit 250 women into the project who will complete a series of questionnaires on a monthly basis throughout pregnancy and the first postpartum year. The first series of questionnaires is provided at 16 weeks. Click here for more information.

Current studies for the Department of Clinical and Biomedical Science:

- TECOS: Trial Evaluating Cardiovascular Outcomes with Sitagliptin in patients with Type 2 Diabetes
-ZiPP
-Natraguard 

  

The National Register of Antipsychotic Medication in Pregnancy (NRAMP)

NRAMP Clinicians Brochure

NRAMP Flyer

The Geelong Bipolar Disorder - Health and Lifestyle Study

This study is currently seeking participants who have been previously diagnosed with bipolar disorder who live in the Geelong region and are aged over 18.

The study will assess psychiatric and medical health outcomes related to bipolar disorder including anxiety disorders and substance use, cardiovascular disease, bone fractures and obesity.  Physical activity, diet quality, sleep, social support and life events will also be assessed in order to examine their relationship with these outcomes. 

The assessment will take between 1 and 2 hours and requires:

·         blood sample

·         bone scan

·         clinical interview

·         questionnaires

We are looking to recruit around 200 participants over the next 12-18 months.  If you or someone you know would be interested in helping us to understand more about this disorder, please contact David Weisinger on 5226 7470, or by email at This e-mail address is being protected from spambots. You need JavaScript enabled to view it